I-APT | CAS#126632-01-7 | Antagonist

MedKoo Cat#: 145031 | Name: I-APT

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Iodoaminopotentidine (I-APT) represents one of the most potent H2-receptor antagonists.

Chemical Structure

I-APT

CAS#126632-01-7

Theoretical Analysis

MedKoo Cat#: 145031

Name: I-APT

CAS#: 126632-01-7

Chemical Formula: C26H34IN7O2

Exact Mass: 603.1819

Molecular Weight: 603.51

Elemental Analysis: C, 51.75; H, 5.68; I, 21.03; N, 16.25; O, 5.30

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

I-APT; IAPT; I APT;

IUPAC/Chemical Name

(Z)-4-amino-N-(2-(3-cyano-2-(3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)guanidino)ethyl)-3-iodobenzamide

InChi Key

VJTYCMQYDRXNNY-UHFFFAOYSA-N

InChi Code

1S/C26H34IN7O2/c27-23-17-21(8-9-24(23)29)25(35)30-11-12-32-26(33-19-28)31-10-5-15-36-22-7-4-6-20(16-22)18-34-13-2-1-3-14-34/h4,6-9,16-17H,1-3,5,10-15,18,29H2,(H,30,35)(H2,31,32,33)

SMILES Code

NC1=C(I)C=C(C=C1)C(=O)NCCN\C(NC#N)=N\CCCOC2=CC=CC(CN3CCCCC3)=C2

Appearance

To be determined

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 603.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Buteau AC, Castelo-Loureiro A, Barragan-Carrillo R, Bejarano S, Kihn-Alarcón AJ, Soto-Perez-de-Celis E. Disparities in Cancer Control in Central America and the Caribbean. Hematol Oncol Clin North Am. 2024 Feb;38(1):35-53. doi: 10.1016/j.hoc.2023.07.007. Epub 2023 Aug 17. PMID: 37597998. 2: Nakayama Y, Sakano S, Shinohara Y, Nishijima J, Ban Y, Hidaka Y, Fukuda M, Shiraishi K. The effect of antiplatelet therapy on outcomes in patients who underwent laparoscopic radical nephrectomy: A Japanese single-center study. Asian J Endosc Surg. 2023 Oct;16(4):679-686. doi: 10.1111/ases.13218. Epub 2023 Jun 20. PMID: 37340623. 3: Li J, Wang J, Ma D, Bai H. Highly sensitive and specific resonance Rayleigh scattering detection of esophageal cancer cells via dual-aptamer target binding strategy. Mikrochim Acta. 2023 Jun 2;190(6):248. doi: 10.1007/s00604-023-05828-6. PMID: 37266700. 4: van der Goot H, Timmerman H. Selective ligands as tools to study histamine receptors. Eur J Med Chem. 2000 Jan;35(1):5-20. doi: 10.1016/s0223-5234(00)00101-x. PMID: 10733599. 5: Zhou L, Gan N, Zhou Y, Li T, Cao Y, Chen Y. A label-free and universal platform for antibiotics detection based on microchip electrophoresis using aptamer probes. Talanta. 2017 May 15;167:544-549. doi: 10.1016/j.talanta.2017.02.061. Epub 2017 Feb 28. PMID: 28340759. 6: Ruat M, Traiffort E, Bouthenet ML, Souil E, Pollard H, Moreau J, Schwartz JC, Martinez-Mir I, Palacios JM, Hirschfeld J, et al. Reversible and irreversible labelling of H1- and H2 -receptors using novel [125I] probes. Agents Actions Suppl. 1991;33:123-44. doi: 10.1007/978-3-0348-7309-3_10. PMID: 1675831. 7: Kaya E, Siebermair J, Azizy O, Dobrev D, Rassaf T, Wakili R. Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator. Int J Cardiol Heart Vasc. 2019 Jul 5;24:100390. doi: 10.1016/j.ijcha.2019.100390. PMID: 31334332; PMCID: PMC6614530. 8: Bill C, Danielson JA, Jones RS. Salivary intercellular adenosine triphosphate testing in primary caretakers: An examination of statistical significance versus diagnostic predictability. Clin Exp Dent Res. 2017 Dec 22;3(6):244-250. doi: 10.1002/cre2.95. PMID: 29744207; PMCID: PMC5839252. 9: Coruzzi G, Adami M, Pozzoli C, Giorgi F, Bertaccini G. Cardiac and gastric effects of histamine H2 receptor antagonists: no evidence for a correlation between lipophilicity and receptor affinity. Br J Pharmacol. 1996 Aug;118(7):1813-21. doi: 10.1111/j.1476-5381.1996.tb15608.x. PMID: 8842448; PMCID: PMC1909814. 10: Ruat M, Traiffort E, Bouthenet ML, Schwartz JC, Hirschfeld J, Buschauer A, Schunack W. Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1658-62. doi: 10.1073/pnas.87.5.1658. PMID: 2308927; PMCID: PMC53541. 11: Traiffort E, Pollard H, Moreau J, Ruat M, Schwartz JC, Martinez-Mir MI, Palacios JM. Pharmacological characterization and autoradiographic localization of histamine H2 receptors in human brain identified with [125I]iodoaminopotentidine. J Neurochem. 1992 Jul;59(1):290-9. doi: 10.1111/j.1471-4159.1992.tb08903.x. PMID: 1351926. 12: Ambepitiya G, Roberts M, Ranjadayalan K, Tallis R. Silent exertional myocardial ischemia in the elderly: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Geriatr Soc. 1994 Jul;42(7):732-7. doi: 10.1111/j.1532-5415.1994.tb06533.x. PMID: 8014348. 13: Honrubia MA, Vilaró MT, Palacios JM, Mengod G. Distribution of the histamine H(2) receptor in monkey brain and its mRNA localization in monkey and human brain. Synapse. 2000 Dec 1;38(3):343-54. doi: 10.1002/1098-2396(20001201)38:3<343::AID-SYN14>3.0.CO;2-M. PMID: 11020238. 14: Davies S, Ballesteros-Merino C, Allen NA, Porch MW, Pruitt ME, Christensen KH, Rosenberg MJ, Savage DD. Impact of moderate prenatal alcohol exposure on histaminergic neurons, histidine decarboxylase levels and histamine H2 receptors in adult rat offspring. Alcohol. 2019 May;76:47-57. doi: 10.1016/j.alcohol.2018.07.007. Epub 2018 Jul 22. PMID: 30557779. 15: Peitsaro N, Sundvik M, Anichtchik OV, Kaslin J, Panula P. Identification of zebrafish histamine H1, H2 and H3 receptors and effects of histaminergic ligands on behavior. Biochem Pharmacol. 2007 Apr 15;73(8):1205-14. doi: 10.1016/j.bcp.2007.01.014. Epub 2007 Jan 12. PMID: 17266939. 16: Martinez-Mir MI, Pollard H, Moreau J, Arrang JM, Ruat M, Traiffort E, Schwartz JC, Palacios JM. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Res. 1990 Sep 3;526(2):322-7. doi: 10.1016/0006-8993(90)91240-h. PMID: 1979518. 17: Traiffort E, Ruat M, Arrang JM, Leurs R, Piomelli D, Schwartz JC. Expression of a cloned rat histamine H2 receptor mediating inhibition of arachidonate release and activation of cAMP accumulation. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2649-53. doi: 10.1073/pnas.89.7.2649. PMID: 1313563; PMCID: PMC48719. 18: Smit MJ, Roovers E, Timmerman H, van de Vrede Y, Alewijnse AE, Leurs R. Two distinct pathways for histamine H2 receptor down-regulation. H2 Leu124 --> Ala receptor mutant provides evidence for a cAMP-independent action of H2 agonists. J Biol Chem. 1996 Mar 29;271(13):7574-82. doi: 10.1074/jbc.271.13.7574. PMID: 8631790. 19: Leurs R, Smit MJ, Menge WM, Timmerman H. Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells. Br J Pharmacol. 1994 Jul;112(3):847-54. doi: 10.1111/j.1476-5381.1994.tb13157.x. PMID: 7921611; PMCID: PMC1910183. 20: Xie SX, Petrache G, Schneider E, Ye QZ, Bernhardt G, Seifert R, Buschauer A. Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine. Bioorg Med Chem Lett. 2006 Aug 1;16(15):3886-90. doi: 10.1016/j.bmcl.2006.05.039. Epub 2006 May 30. PMID: 16730977.